Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Amsterdam UMC Genome Diagnostics Amsterdam University Medical Center, Location AMC Netherlands | 3 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 5 | 1 |
|
ABCC8 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 4 | 1 |
|
Invitae United States | 173 | 119 |
|
Invitae Monogenic Diabetes Panel Invitae United States | 59 | 28 |
|
PreventionGenetics, part of Exact Sciences United States | 101 | 54 |
|
Lysosomal Storage Disorders Panel PreventionGenetics, part of Exact Sciences United States | 242 | 146 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Diabetes mellitus, transient neonatal 2, 610374 (Transient neonatal diabetes mellitus) (MLPA) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Invitae Broad Carrier Screen without X-linked Disorders Invitae United States | 195 | 98 |
|
Invitae United States | 224 | 112 |
|
Invitae Comprehensive Carrier Screen Invitae United States | 886 | 547 |
|
Translational Metabolic Laboratory Radboud University Medical Centre Netherlands | 3 | 1 |
|
Panel of lysosomal disorders and mucopolysaccharidosis. NGS panel of 102 genes. Genologica Medica Spain | 175 | 102 |
|
MODY type diabetes panel. NGS panel of 13 genes. Genologica Medica Spain | 29 | 13 |
|
Comprehensive panel of monogenic diabetes. 28-gene NGS panel. Genologica Medica Spain | 60 | 28 |
|
Hypoglycemia, hyperinsulinism, and ketone metabolism panel. NGS panel of 50 genes. Genologica Medica Spain | 73 | 50 |
|
Diabetes mellitus: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 10 | 10 |
|
Asper Biogene Asper Biogene LLC Estonia | 31 | 12 |
|
Maturity-Onset Diabetes of the Young (MODY) Expanded Genetic Panel MNG Laboratories (Medical Neurogenetics, LLC.) United States | 22 | 11 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.